Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Is Eli Lilly Stock Heading for $1,000?

TheMotleyFool

0 0

Eli Lilly (NYSE: LLY) just delivered another fantastic quarter, showcasing its impressive growth prospects. The company has been a leader in the growing GLP-1 drug market, with fantastic assets in Mounjaro and Zepbound driving much of its growth in recent years.

However, despite its strong growth, the stock has given back gains in recent months and is down from the highs of more than $1,100 that it reached earlier in the year. On Monday, it was trading at around $960. In light of its strong Q1 results, can it get back to $1,000 and potentially hit new highs?

Image source: Getty Images.

Source Fool.com

Like: 0

LLY

Teilen